DMRA
Damora Therapeutics, Inc.
21.30$
+3.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | +69.4% | +134.6% | +11.1% | +69.4% | -78.2% | -81.2% | |
| – | – | – | – | +24.4% | -2.6% | -40.3% | -69.2% | |
| – | – | -309.2% | – | – | -136.6% | – | – | |
| – | – | – | – | -12.1% | -100.0% | – | – | |
| – | – | – | – | – | +80.3% | -47.8% | -249.1% | |
| – | – | – | -100.0% | – | +467.3% | -100.0% | – | |
| – | -163.6% | – | -166.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.